GlobeImmune, Inc.
GBIM
$0.0002
$0.000.00%
OTC PK
| 03/31/2016 | 12/31/2015 | ||||
|---|---|---|---|---|---|
| Revenue | -10.03% | -64.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.03% | -64.42% | |||
| Cost of Revenue | 121.00% | -59.83% | |||
| Gross Profit | -47.48% | -65.54% | |||
| SG&A Expenses | -25.29% | 34.26% | |||
| Depreciation & Amortization | -2.55% | -4.39% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.10% | -0.43% | |||
| Operating Income | 3.66% | -190.08% | |||
| Income Before Tax | -8.45% | -188.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -8.45% | -188.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.45% | -188.97% | |||
| EBIT | 3.66% | -190.08% | |||
| EBITDA | 3.70% | -186.33% | |||
| EPS Basic | -8.47% | -188.93% | |||
| Normalized Basic EPS | 3.70% | -190.09% | |||
| EPS Diluted | -6.24% | -208.54% | |||
| Normalized Diluted EPS | 3.70% | -208.84% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | -17.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||